drugset / Trial / NCT02196636

A Phase 1 Study of RO6806127 in Healthy Male Volunteers

NCT02196636 ↗

Phase 1 Completed 37 enrolled Hoffmann-La Roche
RandomizedParallel-groupDouble-blind

Summary

This two-part study will assess the safety and tolerability of single ascending oral doses of RO6806127 in a group of healthy male participants and investigate the effect of high fat and high caloric food on the relative bioavailability of a single oral dose of RO6806127 in a separate group of healthy male participants. The relationship between drug exposure and tolerability will be explored.

Timeline

Start
2014-07
Primary completion
2015-01
Completion
2015-01

Drugs

EvaluationDrugModalityDoseRoute
Subject RG7342 Unknown — Oral

Indications

No indication recorded.